RELISERA
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Nov 2022)
What this means for you
This application is over — abandoned 21 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88648042
- Mark type
- Stylized text
- Filed
- 09 Oct 2019
- Published for opposition
- 25 Feb 2020
- Abandoned
- 21 Nov 2022
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of nocturia
Owner
- ACERUS PHARMACEUTICALS USA, LLC, FORT WASHINGTON, PA, US
- Serenity Pharmaceuticals LLC, Mississauga, Ontario, DE, US
- Serenity Pharmaceuticals LLC, Milford, PA, US
Prosecution history
- 01 Feb 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2022 — SOU EXTENSION 4 GRANTED
- 31 Mar 2022 — SOU EXTENSION 4 FILED
- 31 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2021 — SOU EXTENSION 3 GRANTED
- 16 Sept 2021 — SOU EXTENSION 3 FILED
- 16 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 16 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2021 — SOU EXTENSION 2 GRANTED
- 12 Mar 2021 — SOU EXTENSION 2 FILED
- 12 Mar 2021 — SOU TEAS EXTENSION RECEIVED